Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

S.R.I.W.

Investor type Government Office

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 105
Average round size
info
The average size of a deal this fund participated in
$11M
Portfolio companies 89
Rounds per year 2.44
Lead investments 20
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.15
Exits 9
Key employees 9
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Manufacturing
  • Pharmaceutical
  • Medical
Summary

S.R.I.W. is the famous Corporate Investor, which was founded in 1979. The venture was found in Europe in Belgium. The main department of described Corporate Investor is located in the Liu00e8ge.

The overall number of key employees were 7.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the S.R.I.W., startups are often financed by SFPI-FPIM, Vesalius Biocapital Partners, Sambrinvest. The meaningful sponsors for the fund in investment in the same round are Vesalius Biocapital Partners, Sambrinvest, Capricorn Venture Partners. In the next rounds fund is usually obtained by SFPI-FPIM, Sambrinvest, Vesalius Biocapital Partners.

The fund is constantly included in 2-6 investment rounds annually. The real fund results show that this Corporate Investor is 4 percentage points more often commits exit comparing to other companies. The usual things for fund are deals in the range of 10 - 50 millions dollars. This S.R.I.W. works on 21 percentage points less the average amount of lead investments comparing to the other organizations. The increased amount of exits for fund were in 2017. The top activity for fund was in 2018. Despite it in 2019 the fund had an activity.

Among the most successful fund investment fields, there are Information Technology, Pharmaceutical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Belgium. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight Minoryx Therapeutics, iSTAR Medical, Miracor Medical.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of S.R.I.W.:
Typical Co-investors
S.R.I.W. is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after S.R.I.W.:

Funds with similar focus

Funds from Belgium
Funds with similar focus located in Belgium:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Aerospacelab

Aerospace
$47M16 Feb 2022 Belgium, Walloon Brabant, Belgium

EyeD Pharma

Biopharma
Biotechnology
Pharmaceutical
$53M24 Dec 2021 Liege, Liège, Belgium

PDC*line Pharma

Biotechnology
Health Care
Therapeutics
$13M06 Dec 2021 France, Auvergne-Rhône-Alpes, France

Sortlist

Advertising
Communications Infrastructure
Information Technology
Internet
Marketing
Peer to Peer
$12M15 Sep 2021 Belgium, Walloon Brabant, Belgium

Vertuoza

Construction
SaaS
$1M07 Jul 2021 Nivelles, Brabant Wallon, Belgium

Imcyse

Biotechnology
Pharmaceutical
Therapeutics
$25M17 Feb 2021 Liège, Liège, Belgium

Univercells

Biotechnology
Health Care
Manufacturing
$23M17 Dec 2020 Charleroi, Hainaut, Belgium

Syndesi Therapeutics

Biotechnology
Health Care
$7M28 Sep 2020 Belgium, Limburg, Belgium

Miracor Medical

Health Care
Health Diagnostics
Medical
Medical Device
Personal Health
$28M02 Sep 2020 Belgium, Liège, Belgium

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent S.R.I.W.?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: